These final results, together with a past report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 assist the notion of concentrating on ACKR3 as a unique strategy to modulate the opioid process, which could open up new therapeutic avenues for opioid-connected disorders. This health and https://jimw580wso0.bligblogging.com/profile